[Effect of levamisole on the cellular immunity indices of patients with active forms of brucellosis].
The dynamics of the content of the main lymphocyte populations and their functional capacity has been studied in patients with acute and subacute brucellosis, receiving levamisole and placebo. The study has shown the immunomodulating influence of levamisole on both the number of all circulating lymphocyte populations under study and their functional activity, which influenced the immediate and remote results of treatment.
Mukovozova
L A
LA
D000208:Acute Disease; D000276:Adjuvants, Immunologic; D000328:Adult; D002006:Brucellosis / Q000188:drug therapy* / Q000276:immunology; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007978:Levamisole / Q000627:therapeutic use*; D008297:Male; D010919:Placebos; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
D000276:Adjuvants, Immunologic; D010919:Placebos; D007978:Levamisole
Vliianie levamizola na pokazateli kletochnogo immuniteta u bol'nykh s aktivnymi formami brutselleza.